Prime Therapeutics Talent Acquisition Specialist Salaries in Minneapolis
The average Prime Therapeutics Talent Acquisition Specialist in Minneapolis earns an estimated $100,981 annually, which includes an estimated base salary of $87,703 with a $13,277 bonus. Prime Therapeutics' Talent Acquisition Specialist compensation is $5,521 more than the US average for a Talent Acquisition Specialist. Talent Acquisition Specialist salaries at Prime Therapeutics in Minneapolis can range from $40,000 - $225,000.
In Minneapolis, The HR Department at Prime Therapeutics earns $3,562 more on average than the Finance Department.
Last updated a year ago.
- $87,703
- avg. base
- $13,277
- avg. bonus
Talent Acquisition Specialist Salaries at Prime Therapeutics
In Minneapolis, Talent Acquisition Specialists earn $5,515 more than Recruiters, and $7,345 less than HR Managers.
Compensation at Prime Therapeutics by Department
In Minneapolis, The HR Department averages $3,562 more than the Finance Department, and $763 less than the Design Department
Talent Acquisition Specialist Compensation by Gender (All Companies)
The average female Talent Acquisition Specialist at companies similar size to Prime Therapeutics reported making $97,893, while the average male Talent Acquisition Specialist at similar sized companies reported making $107,878.
Talent Acquisition Specialist Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Talent Acquisition Specialist at companies similar size to Prime Therapeutics reported making $105,467, while the average African American/Black Talent Acquisition Specialist at similar sized companies reported making $95,882.
How Talent Acquisition Specialists at Prime Therapeutics Rate Their Compensation
The majority of Talent Acquisition Specialists at Prime Therapeutics believe they're compensated fairly. 100% of Talent Acquisition Specialists at Prime Therapeutics say they receive annual bonuses, and the vast majority (77%) are satisfied with their benefits. See more compensation ratings at Prime Therapeutics
